Abstract | OBJECTIVE: METHODS: 232 pathologically confirmed nonsmall cell lung cancer patients were enrolled into this multi-center randomized trial. Of these 232 patients, 116 cases were treated with chemotherapy alone ( chemotherapy group), another 116 with chemotherapy combined with Shenqi-fuzheng injection produced by Lizhu Company ( Shenqi-fuzheng group). Life quality of these patients were evaluated using the QOL scale of European Organization for Research on Treatment of Cancer (QLQ-C30) and the functional living index- cancer. RESULTS: CONCLUSION:
|
Authors | Hong-Sheng Lin, Dao-Rui Li |
Journal | Zhonghua zhong liu za zhi [Chinese journal of oncology]
(Zhonghua Zhong Liu Za Zhi)
Vol. 29
Issue 12
Pg. 931-4
(Dec 2007)
ISSN: 0253-3766 [Print] China |
PMID | 18478934
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Drugs, Chinese Herbal
- Taxoids
- shenqi fuzheng
- Paclitaxel
- Cisplatin
|
Topics |
- Adolescent
- Adult
- Aged
- Antineoplastic Agents, Phytogenic
(administration & dosage, therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, physiopathology)
- Cisplatin
(therapeutic use)
- Drugs, Chinese Herbal
(administration & dosage, therapeutic use)
- Female
- Humans
- Infusions, Intravenous
- Lung Neoplasms
(drug therapy, physiopathology)
- Male
- Medicine, Chinese Traditional
- Middle Aged
- Paclitaxel
- Phytotherapy
- Quality of Life
- Taxoids
(therapeutic use)
- Young Adult
|